Prostate cancer is the third leading cause of cancer death, behind lung cancer and colon cancer, in men. The incidence of prostate cancer has nearly doubled over the past few years. This CME focuses on describing the latest evidence for the early use of chemotherapy and immunotherapy, advances in the surgical techniques, and palliative care in patients with prostate cancer.